(Reuters) Billionaire investor William Ackman on Monday mounted a vigorous defense of Valeant Pharmaceuticals, ruling out any sale of the drug company’s “crown jewel” assets but saying price cuts and even a new name may be in its future…..
Ackman defends Valeant, hints at more changes
This entry was posted in Syndicated. Bookmark the permalink.
